Rene Soria-Saucedo to serve a two-year term at the Pharmacy Quality Alliance
Rene Soria-Saucedo, M.D., Ph.D., an assistant professor of pharmaceutical outcomes and policy, was elected to serve a two-year term at the Risk Adjustment Advisory Group at the Pharmacy Quality Alliance, or PQA. Established in 2006, PQA is a non-profit alliance with over 200 member organizations focused on improving the quality of medication management and use across health care settings, with the goal of improving patient’s health through a collaborative process and recognizing examples of exceptional pharmacy quality. The group is currently focusing on examining the potential effects of socioeconomic factors on Centers for Medicaid and Medicare Services, or CMS, Star Ratings on three PQA medication adherence measures:
- proportion of days covered for diabetes medications
- cholesterol lowering medications (statins)
- blood pressure medications (renin-angiotensin system antagonists)
PQA’s SDS Risk Adjustment Advisory Group has developed a risk adjustment model testing plan for the three adherence measures and will test the models using Medicare Advantage data. Results will be disseminated by CMS. Future work includes refining the risk adjustment model based on initial results, testing the risk adjustment models in additional varied populations and developing and examining risk adjustment models for additional measures.
“The multidisciplinary and independent approach to evaluate the continuity of medication management at PQA are critical elements of their success and relevance,” said Soria-Saucedo. “I feel truly honored to do my part.”
“Dr. Soria-Saucedo will have a significant impact on the field of risk adjustment and predictive modeling science,” said Almut Winterstein, Ph.D., a professor and the Dr. Robert and Barbara Crisafi Chair in pharmaceutical outcomes and policy. “His appointment to the advisory group at PQA is one mechanism by which he will be able to achieve this.”